2023 (24 POSTS)
Wikoff D , Ring C, DeVito M, Walker N, Birnbaum L, Haws L . 2023. Development and application of a systematic and quantitative weighting framework to evaluate the quality and relevance of relative potency estimates for dioxin-like compounds (DLCs) for human health risk assessment. Regul Toxicol Pharmacol 145:105500.
View Abstract
Publication: Manuscripts
Perry CS , Blanchette AD, Vivanco SN , Verwiel AH , Proctor DM . 2023. Use of physiologically based pharmacokinetic modeling to support development of an acute (24-hour) health-based inhalation guideline for manganese. Regul Toxicol Pharmacol 145:105518.
View Abstract
Publication: Manuscripts
Thompson CM , Kirman C, Harris MA . 2023. Derivation of oral cancer slope factors for hexavalent chromium informed by pharmacokinetic models and in vivo genotoxicity data. Regul Toxicol Pharmacol 145:105521.
View Abstract
Publication: Manuscripts
Pastula S , Bylsma LC , Movva N , Rege S, Lewis RJ, Fryzek JP. 2023. Scoping review of indices to monitor community health. Open Science Framework.
Publication: Protocol Registrations
Nelson CB, Jiang X , Suh M , Fryzek J. Prevention of respiratory syncytial virus hospitalizations (RSVH) in US infants who paid through Medicaid would have a greater benefit for Black, Hispanic, Asian/Pacific Islander, Native American and Other race/ethnicity infants, and have a substantial impact on overall RSVH burden and related costs: Rates of respiratory syncytial virus hospitalization (RSVH) among US infants by race/ethnicity and insurance payer, NIS 2018-2020. Poster 1536169, IDWeek 2023, Boston, MA, October 2023.
Publication: Abstracts and Presentations
Blatt A, Suh M , Walter E, Jr., Wood CT, Espinosa C, Enriquez-Bruce ME…Movva N , Reichert H , Fryzek JP, et al. Seasonality of infant respiratory syncytial virus associated bronchiolitis around the US since the onset of COVID-19: Results from four US health systems 2016-17 through 2022-23. Poster 1535431, IDWeek 2023, Boston, MA, October 2023.
Publication: Abstracts and Presentations
Wharton GT, Becker C, Bennett D, Burcu M, Bushnell G, Ferrajolo C, Kaplan S, McMahon AW, Movva N , Raman SR, Scholle O, Suh M , Sun JW, Horton DB. 2023. Overview of global real-world data sources for pediatric pharmacoepidemiologic research. Poster presentation at the 39th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Halifax, Nova Scotia, August 2023 [ISPE Journal ].
View Abstract
Publication: Abstracts and Presentations
Wharton GT, Becker C, Bennett D, Burcu M, Bushnell G, Ferrajolo C,… Movva N , Raman SR, Scholle O, Suh M , et al. 2023. Overview of global real-world data sources for pediatric pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf. doi: 10.1002/pds.5695 . Epub ahead of print. PMID: 37690792.
View Abstract
Publication: Manuscripts
Daniels D, Wang D, Suryadevara M, Wolf Z, Nelson CB, Suh M , Movva N , Reichert H , Fryzek JP, et al. 2023. Epidemiology of RSV bronchiolitis among young children in central New York before and after the onset of the COVID-19 pandemic. Pediatr Infect Dis J . doi: 10.1097/INF.0000000000004101. Epub ahead of print.
View Abstract
Publication: Manuscripts
Mitchell ME , Bylsma LC , Shara NM, Fernandez SJ, Catlett JP, Lai JS, Dong K, Fryzek JP, Daver N, Allen C, Broome CM. Novel methods for the identification of a rare disease, hemophagocytic lymphohistiocytosis (HLH). Poster presented at the International Society for Pharmacoepidemiology annual meeting, Poster 166, Halifax, Nova Scotia, August 2023.
Publication: Abstracts and Presentations
Broome CM, Mitchell M , Bylsma L , Shara N, Fernandez S, Catlett J, Lai J, Dong K, Fryzek J, Daver N, Allen C. Novel methods for the identification of a rare disease, hemophagocytic lymphohistiocytosis (HLH). Poster presented to European Hematology Association, EHA2023, Abstract P1202, Frankfurt, June 2023.
View Abstract
Publication: Abstracts and Presentations
Pundole X, Ju C-H, Bylsma LC , Hooda N , Movva N , Elkhouly E, Bebb DG, Fryzek J, et al. 2023. Prevalence of delta-like ligand 3 expression in small cell lung cancer. J Clinical Oncology 41:16_suppl e20618.
View Abstract
Publication: Abstracts and Presentations
Wharton GT, Becker C, Bennett D, Burcu M, Bushnell G, …, Movva N , …, Suh M , et al. Overview of global real world data sources for pediatric pharmacoepidemiological research. Poster 217, International Society for Pharmacoepidemiology (ICPE) annual meeting, Halifax, Nova Scotia, August 2023.
View Abstract
Publication: Abstracts and Presentations
Wood CT, Walter E, Espinosa CM, Enriquez-Bruce ME, Budhecha S, Elliott A, Domachowske J, Daniels D, Wolf Z, Waddell E, Suh M, Fryzek J, Nelson CB. Seasonality of infant lower respiratory tract infections, including those caused by RSV, was altered during the COVID-19 pandemic: Results from four US health systems. Poster #642 at the Pediatric Academic Societies meeting, Washington, DC, April 2023.
Publication: Abstracts and Presentations
Suh M, Reichert H, Jiang X, Pastula ST, Movva N, Fryzek J, Simoes E. The burden of RSV and bronchiolitis in the US infant Medicaid population extends beyond the inpatient setting. Oral presentation to the Pediatric Academic Societies meeting, Washington, DC, April 2023.
Publication: Abstracts and Presentations
Dalvi T, Nørgaard M, Fryzek JP, Movva N , Pedersen L, Hansen HP, et al. 2023. Biomarker expression and survival in patients with non-small cell lung cancer receiving adjuvant chemotherapy in Denmark. PLoS ONE 18(4):e0284037; doi: 10.1371/journal.pone.0284037 .
View Abstract
Publication: Manuscripts
Suh M , Reichert H , Movva N , Fisher K, Wood CT, Wolf Z, et al. Pilot surveillance of infant lower respiratory tract infections and respiratory syncytial virus in the United States during the COVID pandemic. Poster 95, International Society for Pharmacoepidemiology (ICPE) annual meeting, Halifax, Nova Scotia, August 2023.
View Abstract
Publication: Abstracts and Presentations
Pastula S , Suh M , Jiang X , Reichert H , Movva N , Fryzek J, Simões EAF. Respiratory syncytial virus (RSV) and bronchiolitis epidemiology among the United States infant Medicaid populations in seven states. Poster 191, International Society for Pharmacoepidemiology (ICPE) annual meeting, Halifax, Nova Scotia, August 2023.
View Abstract
Publication: Abstracts and Presentations
Wood CW, Walter E, Espinosa C, Enriquez-Bruce ME, Budhecha S, Elliott A, Domachowske J, Daniels D, Wolf Z, Waddell EB, Suh M , Fryzek J, Nelson CB (presenter) . 2023. (1) Seasonality of infant lower respiratory tract infections, including those caused by RSV, was altered during the COVID-19 pandemic: Results from four US health systems. (2) Infant hospitalizations and ICU admissions for bronchiolitis and RSV-bronchiolitis are at historic highs during 2022 early seasonal disease: Results from four US health systems. Companion posters accepted for the 7th ReSViNET Conference, Respiratory Syncytial Virus Foundation, Lisbon, Portugal, February 2023.
View Abstract